TherapeuticsMD, Inc. Capital Expenditures
TherapeuticsMD, Inc. (TXMD) reported Capital Expenditures of $21.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2023-11-14
- TherapeuticsMD, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $0.00.
- TherapeuticsMD, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-06-30 was -$21.00K, a 151.22% decline year-over-year.
- TherapeuticsMD, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-03-31 was $42.00K, a 33.33% decline year-over-year.
- TherapeuticsMD, Inc. payments to acquire property, plant, and equipment for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- TherapeuticsMD, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $34.00K, a 83.57% decline from fiscal 2020.
- TherapeuticsMD, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $207.00K, a 91.55% decline from fiscal 2019.
- TherapeuticsMD, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $2.45M, a 1028.82% increase from fiscal 2018.
- TherapeuticsMD, Inc. payments to acquire property, plant, and equipment for fiscal 2018 was $217.04K, a 251.10% increase from fiscal 2017.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$21.00K derived: sum of 2 quarters · filed 2023-11-14 | $21.00K 10-Q · filed 2023-11-14 | $21.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $21.00K 10-Q · filed 2023-08-14 | $20.00K 10-Q · filed 2022-08-15 | $21.00K derived: sum of 3 quarters · filed 2023-08-14 | -$49.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $42.00K 10-Q · filed 2023-05-15 | $42.00K derived: sum of 2 quarters · filed 2023-05-15 | -$28.00K derived: sum of 3 quarters · filed 2023-05-15 | $13.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-07 | -$70.00K derived: sum of 2 quarters · filed 2023-04-07 | -$29.00K derived: sum of 3 quarters · filed 2023-04-07 | $34.00K 10-K · filed 2023-04-07 | ||||
| 2021-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$29.00K derived: sum of 2 quarters · filed 2022-11-14 | $34.00K 10-Q · filed 2022-11-14 | $202.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $104.00K 10-Q · filed 2022-08-15 | $272.00K derived: sum of 3 quarters · filed 2022-08-15 | $285.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $63.00K 10-Q · filed 2022-05-16 | $231.00K derived: sum of 2 quarters · filed 2022-05-16 | $244.00K derived: sum of 3 quarters · filed 2022-05-16 | $249.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $181.00K derived: sum of 2 quarters · filed 2022-03-23 | $186.00K derived: sum of 3 quarters · filed 2022-03-23 | $207.00K 10-K · filed 2022-03-23 | $207.07K 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $18.00K derived: sum of 2 quarters · filed 2021-11-12 | $39.00K 10-Q · filed 2021-11-12 | $38.61K 10-Q · filed 2020-11-09 | $399.59K derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2020-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $26.00K 10-Q · filed 2021-08-04 | $25.80K 10-Q · filed 2020-08-07 | $386.59K derived: sum of 3 quarters · filed 2022-03-23 | $1.38M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2020-03-31 | $21.00K 10-Q · filed 2021-05-06 | $21.25K 10-Q · filed 2020-05-06 | $381.59K derived: sum of 2 quarters · filed 2022-03-23 | $1.38M derived: sum of 3 quarters · filed 2022-03-23 | $2.21M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2019-12-31 | $360.59K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.36M derived: sum of 2 quarters · filed 2022-03-23 | $2.19M derived: sum of 3 quarters · filed 2022-03-23 | $2.45M 10-K · filed 2022-03-23 | $2.45M 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $996.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.83M derived: sum of 2 quarters · filed 2020-11-09 | $2.09M 10-Q · filed 2020-11-09 | $2.24M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | $830.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.09M 10-Q · filed 2020-08-07 | $1.24M derived: sum of 3 quarters · filed 2021-03-04 | $1.26M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | $262.42K 10-Q · filed 2020-05-06 | $413.16K derived: sum of 2 quarters · filed 2021-03-04 | $433.74K derived: sum of 3 quarters · filed 2021-03-04 | $452.55K derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | $150.75K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $171.32K derived: sum of 2 quarters · filed 2021-03-04 | $190.13K derived: sum of 3 quarters · filed 2021-03-04 | $217.04K 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $20.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $39.39K derived: sum of 2 quarters · filed 2019-11-08 | $66.30K 10-Q · filed 2019-11-08 | $92.26K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $18.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $45.72K 10-Q · filed 2019-08-09 | $71.69K derived: sum of 3 quarters · filed 2020-02-24 | $71.69K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $26.91K 10-Q · filed 2019-05-08 | $52.88K derived: sum of 2 quarters · filed 2020-02-24 | $52.88K derived: sum of 3 quarters · filed 2020-02-24 | $60.89K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $25.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $25.97K derived: sum of 2 quarters · filed 2020-02-24 | $33.98K derived: sum of 3 quarters · filed 2020-02-24 | $61.82K 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $8.02K derived: sum of 2 quarters · filed 2018-11-08 | $35.85K 10-Q · filed 2018-11-08 | $124.29K derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $8.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $35.85K 10-Q · filed 2018-07-30 | $124.29K derived: sum of 3 quarters · filed 2019-02-27 | $166.97K derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $27.83K 10-Q · filed 2018-05-07 | $116.27K derived: sum of 2 quarters · filed 2019-02-27 | $158.95K derived: sum of 3 quarters · filed 2019-02-27 | $349.51K derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $88.44K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $131.12K derived: sum of 2 quarters · filed 2019-02-27 | $321.68K derived: sum of 3 quarters · filed 2019-02-27 | $396.15K 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $42.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $233.24K derived: sum of 2 quarters · filed 2017-11-07 | $307.71K 10-Q · filed 2017-11-07 | $457.41K derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $190.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $265.04K 10-Q · filed 2017-08-03 | $414.73K derived: sum of 3 quarters · filed 2018-02-23 | $414.73K derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | $74.48K 10-Q · filed 2017-05-03 | $224.18K derived: sum of 2 quarters · filed 2018-02-23 | $224.18K derived: sum of 3 quarters · filed 2018-02-23 | |||||
| 2015-12-31 | $149.70K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $149.70K derived: sum of 2 quarters · filed 2018-02-23 | $165.26K 10-K · filed 2018-02-23 | |||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $15.56K 10-Q · filed 2016-11-04 | ||||||
| 2015-06-30 | $15.56K 10-Q · filed 2016-08-05 | |||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $7.27K derived: sum of 3 quarters · filed 2017-02-28 | $30.96K 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $7.27K derived: sum of 2 quarters · filed 2015-11-05 | $30.96K 10-Q · filed 2015-11-05 | $48.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $7.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $30.96K 10-Q · filed 2015-08-07 | $48.00K derived: sum of 3 quarters · filed 2016-02-26 | $48.85K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $23.69K 10-Q · filed 2015-05-07 | $40.73K derived: sum of 2 quarters · filed 2016-02-26 | $41.58K derived: sum of 3 quarters · filed 2016-02-26 | $41.58K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $17.04K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $17.89K derived: sum of 2 quarters · filed 2016-02-26 | $17.89K derived: sum of 3 quarters · filed 2016-02-26 | $40.79K 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $850.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $850.00 derived: sum of 2 quarters · filed 2014-11-07 | $23.75K 10-Q · filed 2014-11-07 | $21.26K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $22.91K 10-Q · filed 2014-08-07 | $20.41K derived: sum of 3 quarters · filed 2015-03-12 | $22.91K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $22.91K 10-Q · filed 2014-05-07 | $20.41K derived: sum of 2 quarters · filed 2015-03-12 | $22.91K derived: sum of 3 quarters · filed 2015-03-12 | $56.92K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | -$2.50K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.00 derived: sum of 2 quarters · filed 2015-03-12 | $34.02K derived: sum of 3 quarters · filed 2015-03-12 | $66.41K 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $2.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $36.52K derived: sum of 2 quarters · filed 2013-11-05 | $68.90K 10-Q · filed 2013-11-05 | $68.90K derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2012-06-30 | $34.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $66.40K 10-Q · filed 2013-08-07 | $66.40K derived: sum of 3 quarters · filed 2014-03-05 | $69.22K derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2012-03-31 | $32.39K 10-Q · filed 2013-05-10 | $32.39K derived: sum of 2 quarters · filed 2014-03-05 | $35.20K derived: sum of 3 quarters · filed 2014-03-05 | $50.24K derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $2.81K derived: sum of 2 quarters · filed 2014-03-05 | $17.85K derived: sum of 3 quarters · filed 2014-03-05 | $28.77K 10-K · filed 2014-03-05 | ||||
| 2011-09-30 | $2.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $17.85K derived: sum of 2 quarters · filed 2012-11-13 | $28.77K 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | $15.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $25.95K 10-Q · filed 2012-08-09 | ||||||
| 2011-03-31 | $10.91K 10-Q · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |